Alpha Pro Tech Ltd. - 10-Q Summary (Q2 2004)
Business Context and Reporting Period
This filing covers the quarterly period ended June 30, 2004. Alpha Pro Tech Ltd. manufactures and distributes disposable protective apparel, infection control products (masks/shields), extended care products, and consumer goods (pet beds). The company operates primarily in the United States, serving medical, dental, industrial safety, and cleanroom markets. A new "Engineered Products" segment was announced in Q2 2004, focusing on construction weatherization and antimicrobial paints, with manufacturing expected to begin in Q4 2004.
Key Financial Metrics
| Metric | Q2 2004 (3 Months) | Q2 2003 (3 Months) | YTD 2004 (6 Months) | YTD 2003 (6 Months) |
|---|---|---|---|---|
| Sales | $6,748,000 | $8,895,000 | $12,601,000 | $14,251,000 |
| Gross Margin | $3,240,000 (48.0%) | $4,776,000 (53.7%) | $6,230,000 (49.4%) | $7,502,000 (52.6%) |
| Net Income | $450,000 | $1,364,000 | $917,000 | $1,829,000 |
| Diluted EPS | $0.02 | $0.06 | $0.04 | $0.08 |
| Cash & Equivalents | $3,008,000 (as of June 30, 2004) | |||
| Working Capital | $11,372,000 (as of June 30, 2004) | |||
| Debt | $0 (No borrowings on $3.5M credit facility) |
Material Changes vs. Prior Period
- Revenue Decline: Consolidated sales decreased 24.1% in Q2 2004 compared to Q2 2003. This is primarily due to the absence of approximately $3 million in non-core SARS-related mask and shield sales that occurred in Q2 2003.
- Core Growth: Excluding the one-time SARS sales from the prior year, core business sales grew 14.5% in Q2 2004, driven by the Apparel segment (up 18.5%) and Extended Care segment (up 10.1%).
- Profitability: Net income dropped 67.0% year-over-year in Q2. Gross margins compressed from 53.7% to 48.0% due to the loss of high-margin SARS sales and one-time costs of $120,000 related to closing a Mexico facility and starting a new contractor.
- Cash Flow: Operating cash flow turned negative, using $353,000 in the first six months of 2004, compared to providing $115,000 in the same period in 2003. This was driven by increased accounts receivable and prepaid expenses.
Guidance, Outlook, and Risks
- Outlook: Management expects core sales growth to improve in coming quarters due to new sales personnel and product innovation. The new Engineered Products segment is expected to contribute significantly to revenue growth in 2005.
- Capital Expenditures: The company plans to purchase an additional $450,000 of equipment in 2004, primarily for the new Engineered Products subsidiary.
- Liquidity: The company maintains a $3.5 million credit facility with $3.09 million available capacity. Management believes current cash and credit facilities are sufficient for foreseeable working capital and capital expenditure needs.
- Risks: Results could be negatively affected by foreign currency exchange rate fluctuations due to manufacturing in Mexico and China. The company does not hedge these risks.
Investor Verification Checklist
- SARS Impact: Verify the sustainability of the "core" growth rate by analyzing the specific contribution of the Apparel segment versus the volatility of the Mask and Shield segment.
- One-Time Costs: Confirm the full extent of the $120,000 in severance and start-up costs related to the Mexico facility transition and ensure no further similar costs are anticipated.
- Working Capital Trends: Investigate the reasons for the increase in accounts receivable ($603,000 increase YTD) and prepaid expenses, which contributed to negative operating cash flow.
- New Segment Viability: Assess the timeline and capital requirements for the new Engineered Products segment, scheduled to launch in Q4 2004.
- Share Repurchases: Note that the company repurchased 105,000 shares for $194,000 in the first half of 2004; verify if this buyback program remains active.